Bone Sarcoma News Today

Eftilagimod alpha plus radiotherapy and pembrolizumab was safe and displayed initial activity in soft tissue sarcoma.

In this retrospective analysis, outcomes data were evaluated on patients receiving care related to extrapleural pneumonectomy for soft tissue sarcoma or bone sarcoma.

Tests comparing artificial intelligence and standard biopsies revealed that AI had an 86% greater success rate than its competitor, suggests new researc...

A recent study conducted by the Royal Marsden NHS Foundation Trust and the Institute of Cancer Research (ICR) highlights AI's capabilities in assessing cancer aggressiveness.

Researchers have developed an algorithm that predicts how aggressive a tumour is likely to be more accurately than a biopsy.

Researchers in UK say new tool could help ensure patients at high risk are identified promptly

Leveraging the transformative potential of TSL-based tumor targetingSupporting the progress of Thermosomes clinical candidate THE001

Sarcomas are a rare group of cancers that begin in the bones or soft tissues of the body. In other words, sarcoma is a term used to describe bone cancer and cancers that develop in the connective tissues.

Media Release SYDNEY, AUSTRALIA, July 28, 2023 -- Immutep Limited , a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today...

Bone cancer is rare in the UK, accounting for just 1% of all cancer cases.